Eureka!
McKinsey & Company
McKinsey colleagues Alex Devereson and Nav Nagra explore cutting-edge technology trends, tackle pressing industry challenges, and uncover R&D innovations with biopharma leaders. Whether you're a seasoned professional or a curious enthusiast, this series offers valuable insights and thought-provoking discussions that will keep you informed and inspired. Tune in and stay ahead of the curve in the ever-evolving world of biopharma.
Episodes
Mentioned books
Nov 5, 2025 • 30min
Bristol Myers Squibb CDTO Greg Meyers on biopharma’s AI-enabled future
Greg Meyers, Executive Vice President and Chief Digital & Technology Officer at Bristol Myers Squibb (BMS) discusses how technology can be leveraged to drive outcomes.See www.mckinsey.com/privacy-policy for privacy information
Oct 6, 2025 • 24min
Lykke Hinsch Gylvin on the cutting edge of clinical trial design
Lykke Hinsch Gylvin shares how Boehringer Ingelheim’s innovative clinical trial designs bring therapies to patients faster.See www.mckinsey.com/privacy-policy for privacy information
Jun 6, 2025 • 32min
Genentech’s John Marioni on enhancing drug discovery with data and AI
John Marioni discusses how he and his teams across industries and academia use evolving technologies to bring sophisticated drug therapies to patients.See www.mckinsey.com/privacy-policy for privacy information
Mar 27, 2025 • 32min
J&J’s Ashita Batavia on advancing oncology clinical-trials with data
In this episode of Eureka!, a McKinsey podcast on innovation in life sciences R&D, hosts Navraj Nagra, Alex Devereson, and Meredith Langstaff speak to Ashita Batavia, head of hematology and oncology data sciences, R&D, at Johnson & Johnson Innovative Medicine (J&J). They discuss how real-world data can better inform clinical trials, the shifts in mindsets and capabilities needed to support AI in biopharma, and how to navigate the complexity of clinical trials with more-pragmatic trial designs.See www.mckinsey.com/privacy-policy for privacy information
Mar 11, 2025 • 27min
GSK's Kim Branson on driving innovation with AI and machine learning
Kim Branson, Senior VP and Global Head of AI and Machine Learning at GSK, shares her fascinating career journey from structural biology to leading AI initiatives. She delves into how GSK is utilizing machine learning to enhance drug development, focusing on precision medicine in oncology. Kim discusses the importance of combining ML experts with domain specialists and treating data as a strategic asset. She also highlights the future of multimodal datasets from wearables and the significance of responsible AI governance in pharmaceutical innovation.
Nov 18, 2024 • 19min
AbbVie’s head of genomics research on the transformative power of AI
In this episode, Howard Jacob, AbbVie’s vice president of genomics research and head of data integration, discusses early adoption of data integration at AbbVie, the challenges of medical silos, and the steps needed to build novel AI and machine learning capabilities with McKinsey’s Alex Devereson, Erika Stanzl, and Navraj Nagra. Together, explore how AI and genomics can better define diseases and discuss the importance of building trust in new technologies through patient-centric initiatives.See www.mckinsey.com/privacy-policy for privacy information
Sep 18, 2024 • 26min
Advancing R&D for chronic diseases with AI: A conversation with Novo Nordisk’s CSO
Marcus Schindler, chief scientific officer, and head of research and early development at Novo Nordisk, shares the ways in which he's leading the company’s efforts to embrace external innovation and expand into new therapeutic areas with AI as a powerful catalyst for progress with McKinsey colleagues Alex Devereson and Nav Nagra. Learn more about the McKinsey R&D practice here.See www.mckinsey.com/privacy-policy for privacy information
